Cabolong 20mg | Cabozantinib Tablets | for Kidney & Liver Cancer

Introduction of Cabolong 20mg

Cabolong 20 mg is an oral cancer medication that contains Cabozantinib, a tyrosine kinase inhibitor (TKI) used in the treatment of several advanced or metastatic cancers. It is particularly effective for treating renal cell carcinoma (RCC), the most common type of kidney cancer, and hepatocellular carcinoma (HCC), the most common form of liver cancer. It is also approved for use in thyroid cancer in specific cases.

Cabozantinib works by targeting and blocking the activity of multiple tyrosine kinases, including MET, VEGFR, and AXL—enzymes that are involved in tumor growth, angiogenesis (formation of new blood vessels), invasion, and metastasis.

✅ Key Benefits

• Treats advanced renal cell carcinoma (RCC) in adults
  
  

• Approved for hepatocellular carcinoma (HCC) in patients previously treated with sorafenib
  
  

• Also used for medullary thyroid cancer (MTC)
  
  

• Slows down cancer growth, angiogenesis, and metastasis
  
  

• Oral administration makes it convenient for long-term cancer therapy
  
  

✅ Possible Side Effects

Common side effects:

• Fatigue
  
  

• Diarrhea or constipation
  
  

• Decreased appetite
  
  

• High blood pressure
  
  

• Nausea or vomiting
  
  

• Mouth sores
  
  

• Weight loss
  
  

✅ Precautions & Warnings

• Not recommended during pregnancy or breastfeeding
  
  

• Use with caution in patients with liver impairment or recent surgery
  
  

• Monitor for signs of bleeding, high blood pressure, or liver dysfunction
  
  

• Inform your doctor of all medications, vitamins, and herbal supplements you are taking
  
  

• Avoid grapefruit juice, which may increase Cabozantinib levels in the blood
  
  

✅ Storage Instructions

• Store at 20–25°C (68–77°F)
  
  

• Keep away from moisture, heat, and direct sunlight
  
  

• Store in the original packaging
  
  

• Keep out of reach of children and pets
  
  

Cabolong 20 mg (Cabozantinib) is a powerful targeted therapy used in the treatment of kidney, liver, and thyroid cancers. As a multi-kinase inhibitor, it effectively impedes tumor growth and the spread of cancer by disrupting the cellular pathways that tumors rely on. When prescribed by a cancer specialist and taken as directed, Cabolong offers significant benefits in advanced cancer management and can help prolong survival and improve quality of life.